Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease

Chi-Chieh Lai1, Pi-Chang Lee, Chih-Chien Wang

  • 1Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.

Abstract

Insights

A reaction at the bacillus Calmette-Guérin (BCG) inoculation site may indicate Kawasaki disease (KD) in infants. Younger Kawasaki disease patients with BCG site reactions showed distinct clinical and lab findings, suggesting it as an early diagnostic sign.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • The bacillus Calmette-Guérin (BCG) inoculation site reaction is not a primary diagnostic criterion for Kawasaki disease (KD).
  • This reaction is noted in 30-50% of KD patients as an "other clinical finding."
  • Investigating BCG site reactions in KD patients is crucial for understanding its diagnostic utility.

Purpose of the Study:

  • To investigate the clinical characteristics of Kawasaki disease patients with reactions at the BCG inoculation site.
  • To compare BCG-reactive and BCG-nonreactive KD patient groups.

Main Methods:

  • A retrospective study analyzed 145 KD patients diagnosed between September 2000 and August 2010.
  • Clinical presentations, lab results, treatment outcomes, and coronary artery abnormalities were compared between BCG-reactive (BCG(+)) and BCG-nonreactive (BCG(-)) groups.
  • Multivariable logistic regression identified factors associated with BCG site reactions.

Main Results:

  • 31.7% of KD patients (46/145) exhibited a BCG inoculation site reaction.
  • BCG(+) patients were younger, had higher white blood cell and platelet counts, elevated serum potassium, and lower low-density lipoprotein levels.
  • BCG(+) patients experienced shorter fever duration before and after intravenous immunoglobulin treatment.
  • Younger age at diagnosis was significantly associated with BCG site reactions.

Conclusions:

  • A BCG inoculation site reaction can be an early diagnostic indicator for Kawasaki disease in countries with national BCG vaccination programs.
  • This sign is particularly useful for diagnosing KD in younger patients, especially those under six months old.
  • The distinct clinical and laboratory findings in BCG-reactive KD patients warrant further investigation.